Caption Management, LLC Seagen Inc. Call Options Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	SELL	$191.51 - $216.16 $13.4 Million - $15.1 Million	-70,000 Reduced 58.33%	50,000 $10.6 Million
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $22.5 Million - $24.8 Million	120,000 New	120,000 $23.1 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $7.44 Million - $9.91 Million	55,000 New	55,000 $7.53 Million
Q4 2021 Feb 11, 2022	SELL	$142.57 - $190.86 $3.85 Million - $5.15 Million	-27,000 Reduced 45.0%	33,000 $5.1 Million
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $4.05 Million - $4.83 Million	30,000 Added 100.0%	60,000 $9.47 Million
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $4.13 Million - $5.72 Million	30,000 New	30,000 $4.17 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.